🇺🇸 FDA
Pipeline program

Dexmedetomidine

K7581

Approved small_molecule active

Quick answer

Dexmedetomidine for Chronic Post-Surgical Pain is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Chronic Post-Surgical Pain
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials